These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23602993)

  • 1. NCL diseases - clinical perspectives.
    Schulz A; Kohlschütter A; Mink J; Simonati A; Williams R
    Biochim Biophys Acta; 2013 Nov; 1832(11):1801-6. PubMed ID: 23602993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCL Disorders: Frequent Causes of Childhood Dementia.
    Schulz A; Kohlschütter A
    Iran J Child Neurol; 2013; 7(1):1-8. PubMed ID: 24665282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of the NCLs -- status and perspectives.
    Siintola E; Lehesjoki AE; Mole SE
    Biochim Biophys Acta; 2006 Oct; 1762(10):857-64. PubMed ID: 16828266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human pathology in NCL.
    Anderson GW; Goebel HH; Simonati A
    Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.
    Warrier V; Vieira M; Mole SE
    Biochim Biophys Acta; 2013 Nov; 1832(11):1827-30. PubMed ID: 23542453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of the neuronal ceroid lipofuscinoses.
    Mole S; Gardiner M
    Epilepsia; 1999; 40 Suppl 3():29-32. PubMed ID: 10446748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic perspectives in the neuronal ceroid lipofuscinoses.
    Kmoch S; Stránecký V; Emes RD; Mitchison HM
    Biochim Biophys Acta; 2013 Nov; 1832(11):1831-41. PubMed ID: 23274885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal ceroid lipofuscinoses: classification and diagnosis.
    Wisniewski KE; Kida E; Golabek AA; Kaczmarski W; Connell F; Zhong N
    Adv Genet; 2001; 45():1-34. PubMed ID: 11332767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
    Kida E; Golabek AA; Wisniewski KE
    Adv Genet; 2001; 45():35-68. PubMed ID: 11332776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuronal ceroid-lipofuscinoses.
    Haltia M
    J Neuropathol Exp Neurol; 2003 Jan; 62(1):1-13. PubMed ID: 12528813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheno/genotypic correlations of neuronal ceroid lipofuscinoses.
    Wisniewski KE; Zhong N; Philippart M
    Neurology; 2001 Aug; 57(4):576-81. PubMed ID: 11548735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses.
    Morsy A; Carmona AV; Trippier PC
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal ceroid lipofuscinoses.
    Jalanko A; Braulke T
    Biochim Biophys Acta; 2009 Apr; 1793(4):697-709. PubMed ID: 19084560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuronal ceroid-lipofuscinoses: from past to present.
    Haltia M
    Biochim Biophys Acta; 2006 Oct; 1762(10):850-6. PubMed ID: 16908122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses.
    Butz ES; Chandrachud U; Mole SE; Cotman SL
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165571. PubMed ID: 31678159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Batten disease: four genes and still counting.
    Mole SE
    Neurobiol Dis; 1998 Nov; 5(5):287-303. PubMed ID: 10069573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ophthalmological manifestations of neuronal ceroid lipofuscinoses (NCL) : NCL as diseases of brain and retina-the role of ophthalmologists].
    Atiskova Y; Kohlschütter A; Spitzer MS; Dulz S
    Ophthalmologe; 2021 Feb; 118(2):113-118. PubMed ID: 33315139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards understanding the neuronal ceroid lipofuscinoses.
    Kohlschütter A; Schulz A
    Brain Dev; 2009 Aug; 31(7):499-502. PubMed ID: 19195801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal Ceroid Lipofuscinosis Type 6 (CLN6) clinical findings and molecular diagnosis: Costa Rica's experience.
    Badilla-Porras R; Echeverri-McCandless A; Weimer JM; Ulate-Campos A; Soto-Rodríguez A; Gutiérrez-Mata A; Hernández-Con L; Bogantes-Ledezma S; Balmaceda-Meza A; Brudvig J; Sanabria-Castro A
    Orphanet J Rare Dis; 2022 Jan; 17(1):13. PubMed ID: 35012600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current state of clinical and morphological features in human NCL.
    Goebel HH; Wisniewski KE
    Brain Pathol; 2004 Jan; 14(1):61-9. PubMed ID: 14997938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.